Cowen Reiterates Buy Rating for Aduro BioTech (ADRO ... - BharataPress

Fairfield Current
Cowen Reiterates Buy Rating for Aduro BioTech (ADRO ...
BharataPress
Cowen reiterated their buy rating on shares of Aduro BioTech (NASDAQ:ADRO) in a report published on Wednesday. Aduro BioTech Inc logo. Several other ...
Brokerages Expect Aduro BioTech Inc (ADRO) to Post -$0.31 EPS ...Fairfield Currenttutte le notizie (5) »